C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2004
10/14/2004	US20040203031 by comparing the mRNA levels of a gene that responds to the drug, such as a steroid; for drug screening
10/14/2004	US20040203030 for drug screening cyclooxygenases for use in conditions including cell proliferation, inflammatory/immune responses, smooth muscle contraction, maintenance of fluid/electrolyte balance, platelet aggregation, production of extracellular matrix proteins
10/14/2004	US20040203029 Method for the specific fast detection of threadlike bacteria
10/14/2004	US20040203025 kit comprising extension, strand displacement, and optionally a termination sequence and with the amplification optionally involving transcription; genetic engineering
10/14/2004	US20040203024 Modified oligonucleotides for use in RNA interference
10/14/2004	US20040203023 Proteins, genes and their use for diagnosis and treatment of breast cancer
10/14/2004	US20040203020 Self-replicating RNA molecule from hepatitis C virus
10/14/2004	US20040203019 Methods and compositions for transcription-based nucleic acid amplification
10/14/2004	US20040203018 kits for quality assurance in the diagnostic detection of complex genetic diseases such as cystic fibrosis and nucleic acid assays to detect components associated with an environmental condition or a biological organism
10/14/2004	US20040203017 utilize the abilities to over and/or under express the product in a cell, as well as the combination of these results, to permit the identification of at least one of the product's cellular or in vivo functionality
10/14/2004	US20040203014 Neurotransmisson-associated proteins
10/14/2004	US20040203011 Fusion genes associated with acute megakaryoblastoc leukemias
10/14/2004	US20040203010 Compositions and methods for gender sorting
10/14/2004	US20040203008 Method of determining nucleic acid base sequence
10/14/2004	US20040203005 Dual hybridization of complex nucleic acid samples for sequencing and single-nucleotide polymorphism identification
10/14/2004	US20040203004 Diagnostic apparatus and method
10/14/2004	US20040203003 comprising isolating messenger RNA and performing reverse transcription polymerase chain reaction (PCR) and assessing the concentrations of the resulting amplicons; genetic engineering
10/14/2004	US20040203002 Determination of protein-DNA specificity
10/14/2004	US20040203000 Cell-signaling assays
10/14/2004	US20040202998 Method of amplifying or detecting HIV-1 RNA
10/14/2004	US20040202997 by a combination of nucleic acid amplification and molecular weight determination using primers which bracket variable sequence regions that uniquely identify a base composition signature (BCS)
10/14/2004	US20040202996 comprises a primary screen of a sample for nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers; significantly reduces number of false positive results
10/14/2004	US20040202994 allows for subsequent analysis; comprises nanocapillary array, with charged membrane, driven by electroosmotic flow; solid phase synthesis
10/14/2004	US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins.
10/14/2004	US20040202647 T cell line specific for a nitrotyrosine-containing compound; antibody specific for a self-antigen comprising a tyrosine to nitrotyrosine conversion; prevention and treatment of autoimmune diseases, infectious diseases and cancer through the recognition of compounds containing nitrated tyrosine residues
10/14/2004	US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/14/2004	US20040202610 Method and apparatus including use of metalloporphyrins for subsequent optimization of radiosurgery and radiotherapy
10/14/2004	US20040202603 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils
10/14/2004	US20040200721 Biosensor
10/14/2004	US20040200720 Electrochemical-sensor design
10/14/2004	DE10392159T5 Biosensor, Biosensorchip und Biosensoreinrichtung Biosensor, biosensor chip and biosensor
10/14/2004	DE10321490B3 Electrochemical sensor, as a biochip working on a redox cycling principle, has one circuit is a potentiostat coupled to the sensor electrode and a second circuit has a condenser for potential comparison
10/14/2004	DE10315840A1 Control system for merchandise, useful particularly for labeling cereals to identify e.g. origin or producer, comprises molecular information carriers, specifically nucleic acid, and analytical device for them
10/14/2004	DE10315640A1 Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung A method for controlled release of components in a solution
10/14/2004	DE10315031A1 In vitro detection of systemic inflammatory response syndrome and related conditions, for e.g. monitoring progression, comprises detecting abnormal expression of disease-related genes
10/14/2004	DE10314745A1 Isothermal cyclic amplification of nucleic acid, useful e.g. for detecting mutations by the arrayed primer extension method, comprises that helicase is used for separation of nucleic acid strands
10/14/2004	DE10314579A1 Apparatus for sequence analysis of nucleic acids has channels with fixed metal particles, where the sample is moved past them with an excitation beam for fluorescence to be passed through spectral analysis for evaluation
10/14/2004	DE10313636A1 Verwendung von Wirksubstanzen zur Vorbeuge oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen The use of active substances for the prevention or treatment of viral diseases and Test System for Finding such active substances
10/14/2004	DE10313515A1 Biochip for pixel-oriented photometric detection of biomolecules, comprises a transparent plastic surface with spots that are functionalized so that the biochip can be used in an assay
10/14/2004	CA2752312A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2752247A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2752244A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2752218A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2525482A1 Improved system for multicolor real-time pcr comprising 3 to 6 pairs of forester resonance energy transfer (fret) probes
10/14/2004	CA2521068A1 Comparative genomic hybridization
10/14/2004	CA2521032A1 Non-invasive prenatal genetic diagnosis using transcervical cells
10/14/2004	CA2520868A1 Staphylococcus epidermidis antigens
10/14/2004	CA2520846A1 Aptamer selection method
10/14/2004	CA2520811A1 Method of cdna synthesis
10/14/2004	CA2520671A1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
10/14/2004	CA2520664A1 Targeting enzymes of the trna splicing pathway for identification of anti-fungal and/or anti-proliferative molecules
10/14/2004	CA2520510A1 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-fungal agents
10/14/2004	CA2520415A1 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-proliferative agents
10/14/2004	CA2520406A1 Cxcr4 antagonists and methods of their use
10/14/2004	CA2520181A1 Selected rna motifs to include cell death and/or apoptosis
10/14/2004	CA2519767A1 Improvements in or relating to viability
10/14/2004	CA2519674A1 Genomic profiling of regulatory factor binding sites
10/14/2004	CA2519554A1 System and method for rapidly identifying pathogens, bacteria and abnormal cells
10/14/2004	CA2519491A1 Markers for roscovitine
10/14/2004	CA2519368A1 Statistical analysis of regulatory factor binding sites of differentially expressed genes
10/14/2004	CA2519309A1 Dna polymerase fusions and uses thereof
10/14/2004	CA2519307A1 Cell cycle related markers
10/14/2004	CA2518882A1 Apparatus and methods for providing sex-sorted animal sperm
10/14/2004	CA2514938A1 Method for detecting escherichia coli
10/14/2004	CA2464175A1 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia
10/14/2004	CA2424575A1 Method of detecting epigenetic biomarkers by quantitative methylsnp analysis
10/13/2004	EP1467211A1 Method for the measurement of chemical groups bonded to biological molecules
10/13/2004	EP1466988A2 Genes and gene expression products that are differentially regulated in prostate cancer
10/13/2004	EP1466986A1 Method for testing the efficacy of gassterilisation, especially sterilisation with ethyleneoxide
10/13/2004	EP1466985A2 Methods for measuring bacteria, bacteria measuring apparatuses, and storage media for storing computer-executable programs for analyzing bacteria
10/13/2004	EP1466973A1 Characteristic base sequences occurring in plant genes and method of utilizing the same
10/13/2004	EP1466663A1 Quality control method for manufacturing nucleic acid arrays
10/13/2004	EP1466624A1 Drug for regenerating tissue and vessel and method therefor
10/13/2004	EP1466616A2 Use of CASB616 polypeptides and polynucleotides for cancer treatment
10/13/2004	EP1466605A2 Calcium channel blockers
10/13/2004	EP1466289A2 Nonlinear system identification for class prediction in bioinformatics and related applications
10/13/2004	EP1466178A1 Screening methods and the use of agents identified using the same
10/13/2004	EP1466177A2 Discovery of therapeutic products
10/13/2004	EP1466175A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/13/2004	EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
10/13/2004	EP1466173A2 Toxicity test
10/13/2004	EP1466156A2 Biosensor membranes composed of polymers containing heterocyclic nitrogens
10/13/2004	EP1466019A2 Detection of human papillomavirus e6 mrna
10/13/2004	EP1466018A2 Use of silica material in an amplification reaction
10/13/2004	EP1466017A2 Tissue rejection
10/13/2004	EP1466016A2 Cancer profiles
10/13/2004	EP1466015A2 Bioconjugate-nanoparticle probes
10/13/2004	EP1466014A2 Chemical and biological hazard sensor system and methods thereof
10/13/2004	EP1466012A2 Nucleotide polymorphisms associated with osteoporosis
10/13/2004	EP1466011A2 New primers for the detection and identification of bacterial indicator groups and virulence factors
10/13/2004	EP1466010A2 Method and system for identifying splice variants of a gene
10/13/2004	EP1466009A2 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6.8 difluoro-4-methyl-umbelliferylphosphate
10/13/2004	EP1466007A1 Non-or minimally invasive monitoring methods
10/13/2004	EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/13/2004	EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors
10/13/2004	EP1465996A2 Raf/ras binding compounds
10/13/2004	EP1465993A2 Inducible transposition in transgenic organism using transposon vector
10/13/2004	EP1465983A2 Endothelial stem cells, populations, methods of isolation and use thereof
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465919A2 Insect g protein-coupled receptor genes and uses thereof

1 ... 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 ... 3003